Not Rated
|
Fund Size
(0.02% of Investment in Category)
|
Expense Ratio
(2.12% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 28-Oct-25 | 10099.70 | 1.00% | - | -0.26% | 22/244 |
| 1 Month | 03-Oct-25 | 10552.10 | 5.52% | - | 2.33% | 3/246 |
| 3 Month | 04-Aug-25 | 10150.30 | 1.50% | - | 3.89% | 208/243 |
| 6 Month | 02-May-25 | 10674.40 | 6.74% | - | 9.89% | 170/232 |
| YTD | 01-Jan-25 | 9980.30 | -0.20% | - | 4.45% | 149/219 |
| Since Inception | 06-Dec-24 | 10130.00 | 1.30% | 1.43% | 12.61% | 194/218 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| No Data Found | |||||
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 128.5 | 12.26% | -0.02% | 13.47% (Dec 2024) | 0% (Oct 2024) | 80.57 k | -2.14 k |
| Divis Laboratories Ltd. | Pharmaceuticals | 88.1 | 8.40% | -0.44% | 8.84% (Aug 2025) | 0% (Oct 2024) | 15.48 k | 0.00 |
| Max Healthcare Institute Ltd. | Hospital | 77.6 | 7.40% | -0.08% | 7.94% (Jun 2025) | 0% (Oct 2024) | 69.59 k | 0.00 |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 67.2 | 6.41% | -0.03% | 6.52% (Dec 2024) | 0% (Oct 2024) | 54.89 k | 0.00 |
| Aster DM Healthcare Ltd. | Hospital | 63.9 | 6.09% | 0.39% | 6.09% (Sep 2025) | 0% (Oct 2024) | 1.02 L | 0.00 |
| Mankind Pharma Ltd. | Pharmaceuticals | 54.7 | 5.22% | 0.05% | 5.22% (Sep 2025) | 0% (Oct 2024) | 22.45 k | 0.00 |
| J.b. Chemicals & Pharmaceuticals Ltd. | Pharmaceuticals | 49.2 | 4.70% | 2.53% | 4.7% (Sep 2025) | 0% (Oct 2024) | 28.79 k | 15.27 k |
| Krishna Institute of Medical Sciences Ltd. | Hospital | 41 | 3.91% | -0.04% | 3.95% (Aug 2025) | 0% (Oct 2024) | 58.58 k | 0.00 |
| Abbott India Ltd. | Pharmaceuticals | 34.8 | 3.32% | -0.16% | 3.79% (Jun 2025) | 0% (Oct 2024) | 1.19 k | 0.00 |
| Global Health Ltd. | Hospital | 34.8 | 3.32% | -0.07% | 3.39% (Aug 2025) | 0% (Oct 2024) | 26.47 k | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 1.62% |
| Net Receivables | Net Receivables | 0.08% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 406.67 | 1.21 | 25.85 | 62.14 | 44.67 | 39.94 |
| Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 266.19 | 0.49 | 7.07 | 21.92 | 31.82 | 18.90 |
| Franklin Asian Equity Fund - Growth | NA | 279.13 | 3.82 | 13.81 | 26.10 | 22.99 | 16.89 |
| Nippon India Japan Equity Fund - Growth | NA | 289.73 | 0.94 | 8.28 | 17.67 | 21.26 | 19.07 |
| HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1651.55 | 0.97 | 10.70 | 28.32 | 20.86 | 0.00 |
| DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1419.62 | 3.87 | 6.50 | 9.87 | 17.88 | 0.00 |
| Quant BFSI Fund - Regular Plan - Growth | NA | 655.17 | 2.89 | 4.01 | 19.21 | 17.19 | 0.00 |
| ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 311.03 | 4.97 | 6.52 | 8.15 | 16.69 | 13.64 |
| SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 8693.07 | 3.25 | 5.77 | 10.36 | 16.48 | 19.38 |
| Motilal Oswal Business Cycle Fund - Regular Plan - Growth | NA | 1984.52 | 4.95 | 4.21 | 14.23 | 15.06 | 0.00 |
Out of 27 mutual fund schemes offered by this AMC, 1 is/are ranked 5 * , 2 is/are ranked 4 * , 4 is/are ranked 3 * , 5 is/are ranked 2 * , 2 is/are ranked 1 * , and 13 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| PGIM India Midcap Fund - Growth | 2 | 11326.40 | 1.72 | 2.17 | 10.13 | 5.72 | 13.21 |
| PGIM India Flexi Cap Fund - Growth | 3 | 6193.15 | 3.12 | 4.22 | 8.39 | 6.90 | 13.55 |
| PGIM India Global Equity Opportunities Fund of Fund - Growth | NA | 1614.87 | 0.75 | 10.98 | 20.90 | 15.14 | 25.70 |
| PGIM India Global Equity Opportunities Fund of Fund - Growth | NA | 1614.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PGIM India Small Cap Fund - Regular Plan - Growth | 3 | 1567.96 | 2.95 | 3.27 | 16.49 | 2.93 | 14.36 |
| PGIM India Balanced Advantage Fund - Growth | NA | 938.46 | 2.10 | 2.30 | 4.99 | 5.44 | 10.16 |
| PGIM India Large and Midcap Fund - Regular Plan - Growth | NA | 763.24 | 2.25 | 2.91 | 7.80 | 8.09 | 0.00 |
| PGIM India ELSS Tax Saver Fund - Growth | 2 | 757.48 | 3.10 | 3.07 | 5.43 | 5.82 | 12.79 |
| PGIM India Emerging Markets Equity Fund of Fund - Growth | NA | 675.50 | 0.00 | 12.39 | 22.15 | 18.53 | 17.93 |
| PGIM India Large Cap Fund - Growth | 2 | 592.77 | 2.92 | 4.21 | 5.61 | 6.92 | 12.00 |